Encapsulated Synbiotic Dietary Supplementation at Different Dosages to Prevent Vibriosis in White Shrimp, Litopenaeus vannamei by Zubaidah, Anis et al.
ble at ScienceDirect
HAYATI Journal of Biosciences 22 (2015) 163e168Contents lists availaHOSTED BY
HAYATI Journal of Biosciences
journal homepage: http: / /www.journals .elsevier .com/
hayat i - journal-of-biosciencesOriginal research articleEncapsulated Synbiotic Dietary Supplementation at Different Dosages
to Prevent Vibriosis in White Shrimp, Litopenaeus vannamei
Anis Zubaidah, Munti Yuhana,* Widanarni
Department of Aquaculture, Faculty of Fisheries and Marine Science, Bogor Agricultural University, Darmaga Campus, Bogor 16680, Indonesia.a r t i c l e i n f o
Article history:
Received 24 June 2014
Accepted 6 April 2015
Available online 11 December 2015
KEYWORDS:
dosage,
Litopenaeus vannamei,
microencapsulation,
synbiotic,
vibriosis* Corresponding author.
E-mail address: myhn@gmx.ch (M. Yuhana).
Peer review under responsibility of Institut Perta
http://dx.doi.org/10.1016/j.hjb.2015.10.007
1978-3019/Copyright © 2016 Institut Pertanian Bogo
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
The aim of this study was to evaluate the effect of encapsulated synbiotic (Bacillus sp. NP5 and oligo-
saccharide) dietary at different dosages on growth performance, survival rate, feed conversion ratio, and
immune responses of Litopenaeus vannamei against Vibrio infection. The shrimps of the main treatments
were fed by the diet that contained three different dosages of encapsulated synbiotic [0.5% (A), 1% (B),
and 2% (C) (w/w)] with feeding rate of 5% of shrimp biomass (4 times a day). The shrimps of two control
treatments (negative control and positive control) were fed only by commercial feed without supple-
mentation of encapsulated synbiotic. The growth, feed conversion ratio, and survival rate were observed
after 30 days of encapsulated synbiotic dietary. The shrimps were then challenged by injection of Vibrio
harveyi (6 log colony forming units/mL) 0.1 mL/shrimp, excluded the negative control treatment. Af-
terward, the survival and immune responses were observed for 9 days after experimental infection. The
shrimps treated with 2% encapsulated synbiotic (treatment C) in the diet showed the highest growth
performance (2.98 ± 0.42%), feed conversion ratio (1.26 ± 0.19), and better immune responses i.e. total
hemocyte counts, differential hemocyte count, phenoloxidase, and intestine bacteria observation
compared to those of positive control treatment.
Copyright © 2016 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Pacific white shrimp (Litopenaeus vannamei) is an
economically important commodity of Indonesian aquaculture.
However, shrimp production decreased since 1990s and resulted in
high economic losses due to viral and bacterial diseases (Austin and
Zhang 2006; Flegel and Sritunyalucksana 2011; Li and Xiang 2012).
One of the major bacterial disease problems is luminous vibriosis.
Among genus Vibrio, V. harveyi is the major causative agent of
luminous vibriosis (Robertson et al. 1998). Luminous vibriosis has
been reported to be one of the bacterial diseases responsible for the
larval massmortality (Chrisolite et al. 2008). Vibrio infection caused
even more shrimp mortality when the viral co-infection occurred
(Hasan 2011).
Along with restriction of antibiotics application in shrimp cul-
ture, the luminous disease control has been done by feed supple-
mentation of prebiotics (Li et al. 2007), probiotics (Guo et al. 2009;
Rivera et al. 2014) and also synbiotics (Li et al. 2009; Arangure et al.nian Bogor.
r. Production and hosting by Els2013; Ramirez et al. 2013). Synbiotics which is a combination of
prebiotics and probiotics could increase the health status by
contributing the modulation of intestinal microflora in the host
(Liong 2008; Chakraborti 2011). The synbiotic application as fresh
preparation, however has been considered ineffective, because of
the short period of cell viability (Weinbreck et al. 2010). The syn-
biotic supplementation as a dry form provides longer cell viability
(Ross et al. 2005; Ubbink and Krueger 2006). Therefore, synbiotic
microencapsulation process is required. This technique is
attemptable, more efficient for practical uses, and protects longer
the cells viability (Anal and Singh 2007). Until the current studies
the research of supplementation of encapsulated synbiotic to
L. vannamei is still limited, where the optimum dosage could be an
important factor to get optimal host performance.2. Materials and Methods
This study was conducted within two steps. First, the micro-
encapsulation process of synbiotic and second, the application of
encapsulated synbiotic for in vivo test. Synbiotic was prepared from
oligosaccharide extract of sweet potato (Ipomoea batatas L.) as the
prebiotic, and Bacillus sp. NP5 as probiotic bacteria which wereevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Figure 1. SR of L. vannamei. Different letters over each treatment bar (mean ± standard
error) indicate significant difference (p < 0.05). A: 0.5% encapsulated synbiotic dietary;
B: 1% encapsulated synbiotic dietary; and C: 2% encapsulated synbiotic dietary. ( )
Before V. harveyi infection, ( ) after V. harveyi infection. NC ¼ negative control;
PC ¼ positive control; SR ¼ survival rate.
A. Zubaidah, et al164marked by rifampicin resistancy (50 mg/mL). Sweet potato as pre-
biotic source used in this study was obtained from sweet potato
research center (Balitkabi), East Java. The preparation of prebiotic
according to the method of Marlis (2008) was conducted at
Nutrition Laboratory, and the probiotic was prepared at Fish Health
Laboratory, Department of Aquaculture, Faculty of Fisheries and
Marine Sciences, Bogor Agriculture University. Synbiotic microen-
capsulation process was done at SEAFAST Center Laboratory, Bogor
Agricultural University. The selected materials used for microen-
capsulation process were whey protein and maltodextrin.
The shrimps (L. vannamei) with initial weight of 2.43 ± 0.26 g
were obtained from Situbondo Brackishwater Aquaculture Devel-
opment Center (BBAP), East Java, Indonesia. The shrimps were
cultured in plastic aquaria (each with a dimension of
60 40 35 cm3). This experiment was conducted in a completely
randomized design with five treatment diets including three dos-
ages of encapsulated synbiotic diet [0.5% (A), 1% (B), and 2% (w/w)
(B), as well as positive control (PC), and negative control (NC)]. Each
treatment was conducted in four replications. The initial densities
were 10 shrimps of each tank. Each tank containing 35 L of sea
water and kept under controlled conditions (temperature was
ranging from 28 to 29 C, salinity was from 33 to 34 ppt, total
ammonia nitrogen was ranging from 0.02 to 0.66 mg/L, dissolved
oxygenwas ranging from 5 to 6.5 mg/L, and pHwas from 7.6 to 7.9).
Faeces and uneaten food were sucked out at the same time of water
replacement, which was done every day (after the first feeding) up
to 10 L.
The experimental diets were prepared by adding the encapsu-
lated synbiotic (0.5%, 1%, and 2% g/kg) to the diet. The control
treatment diets were added only with egg white and without
supplementation of encapsulated synbiotic. Feed used in this study
was commercial shrimp feed pellet (containing 36% protein, 5% fat,
4% fiber, 12% moisture and 15% ash). Feed mixing process was
sprayed manually for each treatment. Encapsulated synbiotic
weighed according to the treatment and then egg white added as
the binder [2% (v/w)] from the total feeding rate (Wang 2007). Feed
that has beenweighed according to the feeding ratewas then put in
the mixture homogenously. Feeding was done four times a day (at
07.00; 11.00; 15.00 and 19.00) for 30 days.
After 30 days of encapsulated synbiotic dietary, specific
growth rate (SGR) and feed conversion ratio (FCR) were observed.
On 31st day, shrimps in the treatments A, B, C, and PC were
challenged by injecting 0.1 mL/shrimp with V. harveyi intramus-
cularly in the cell density of 6 log colony forming unit (CFU)/mL,
whereas treatment NC was only injected by phosphate buffer
saline 0.1 mL/shrimp. V. harveyi used in this study was genetically
marked by rifampicin resistancy (50 mg/mL). Observations of
immune response parameters included the total hemocyte counts
(THCs), the differential hemocyte count (DHC) according to the
method of Hai and Fotedar (2009) and the phenoloxidase (PO)
according to the method of Liu and Chen (2004). Immune re-
sponses were observed on 30th, 32nd and 40th day after the initial
treatment, while intestine bacteria (total plated) was observed on
0, 30th, 32nd, 35th and 40th day.
Shrimp intestine was isolated and weighed (g) and then put in a
microtube that contained 1 mL of phosphate buffer saline (NaCl
0.8%, K2HPO4 0.15%, Na2HPO4 0.02% and KCl 0.02%). After homog-
enization, mixture was serially diluted and plated by performing
total plate count (Li et al. 2009). Themedia used for total plate count
were sea water complete (SWC) (bacto peptone 0.5%, yeast extract
0.1%, glycerol 0.3%, bacto agar 2%, sea water 75%, and distilled water
25%) without rifampicin for total viable bacterial count, SWC with
rifampicin (50 mg/mL) for counting the Bacillus NP5 which resis-
tant to Rifampicin (RfR) and thiosulphate citrate bile-salt sucrose
(TCBS Criterion, USA) for counting the V. harveyi RfR.The experiment was conducted in a completely randomized
design. Significant differences of regressions of survival rate (SR),
SGR and FCR were tested by analysis of variance. The results which
showed differences were tested by least significance different test.
The immune responses are showed in graphs and analyzed
descriptively.
3. Results
SR of shrimp was observed for 30 days before and 9 days after
V. harveyi infection (Figure 1). The encapsulated synbiotic dietary
before challenge test did not show a significant different effect on
SR. However, after challenge test it showed a significant
difference (p < 0.05) among shrimps fed with encapsulated syn-
biotic dietary and infected with V. harveyi i.e. treatment A
(93.33 ± 5.77%); B (93.33 ± 5.77%); and C (93.33 ± 11.55%); and
shrimps without encapsulated synbiotic dietary and infected with
V. harveyi (PC), that is 63.33 ± 5.77%. NC treatment showed the
highest SR (100 ± 0%).
Nomortality occurred during encapsulated synbiotic dietary (30
days before challenge test) for all treatments (Figure 2). Mortality
started to occur from 32nd day (1st day after V. harveyi infection) at
PC treatment and continued until 36th day. The mortality of
shrimps fed with encapsulated synbiotic dietary (treatment A, B,
and C) occurred at 33rd day and until 35th day.
SGR and FCRwere observed after encapsulated synbiotic dietary
(30 days before infection). The result of feeding, growth perfor-
mance (SGR), is presented in Figure 3. The result clearly showed the
beneficial effects of encapsulated synbiotic dietary on SGR of
L. vannamei. The shrimps that supplemented with encapsulated
synbiotic have significant increase of SGR in comparison to the
control treatments (both negative and PC) (p < 0.05). The experi-
mental treatments of this study were significantly different for all
treatments. The greatest effect was obtained in treatment C [2% (w/
w) encapsulated synbiotic dietary] which had a value of
2.98 ± 0.42%, and then treatment B (2.69 ± 0.3%), treatment A
(2.23 ± 0.16%), NC treatment (2.12 ± 0.31%), and PC treatment
(2.09 ± 0.23%). Both NC and PC control treatments before chal-
lenged test were fed by the same treatments, so there was no sig-
nificant difference between them.
The FCRs of shrimps fed by encapsulated synbiotic were lower
compared with the control treatment (p < 0.05) (Figure 4). The
lowest FCR valuewas showed by treatment C (1.26 ± 0.19), followed
by treatment B (1.56 ± 0.25), then treatment A (1.89 ± 0.08),
PC (1.97 ± 0.27), and NC (1.99 ± 0.25).
Immune response of L. vannamei was observed at the pre-
challenge test of V. harveyi (30th day), 1 day after challenge test
(32nd day), and 9 days after challenge test (40th day). Observations
Figure 2. Mortality rate after the challenge test of L. vannamei at differential dosages of
encapsulated synbiotic dietary. A: 0.5% encapsulated synbiotic dietary; B: 1% encap-
sulated synbiotic dietary; and C: 2% encapsulated synbiotic dietary. NC ¼ negative
control; PC ¼ positive control.
Figure 3. SGR of L. vannamei. Different letters over each treatment bar
(mean ± standard error) indicate significant difference (p < 0.05). A: 0.5% encapsulated
synbiotic dietary; B: 1% encapsulated synbiotic dietary; and C: 2% encapsulated syn-
biotic dietary. NC ¼ negative control; PC ¼ positive control; SGR ¼ specific growth rate.
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testinal bacterial population. Total hemocyte after 30 days of
encapsulated synbiotic dietary on treatment A, B and C has
increased higher than the control treatments (Figure 5). TheFigure 4. FCR of L. vannamei. Different letters over each treatment bar
(mean ± standard error) indicate significant difference (p < 0.05). A: 0.5% encapsulated
synbiotic dietary; B: 1% encapsulated synbiotic dietary; and C: 2% encapsulated syn-
biotic dietary. FCR ¼ feed conversion ratio; NC ¼ negative control; PC ¼ positive
control.increase also occurred after the challenge test (32nd day) in all
treatments. However, at the 40th day, total hemocytes decreased in
all treatments.
PO values of encapsulated synbiotic dietary (30th day) showed
improvement, especially in treatment C (Figure 6). These results
indicated that encapsulated synbiotic dietary was able to stimulate
the shrimp immune system by increasing the activity of PO. After
challenge test the PO value also increased in all treatments,
including control treatments, except for treatment C. Before
V. harveyi infection, the treatment of encapsulated synbiotic dietary
resulted in higher granular cells compared with control treatments
(Figure 7). The same results were showed at the time after chal-
lenge test and at the end of observation (40th day).
The intestinal bacterial population were observed at 0 (before
treatment), 30th, 32th, 35th, and 40th day (the last day of treatment).
The observation included bacterial abundance/TVBC, V. harveyi RfR
count, and Bacillus NP5 RfR count. The number of bacteria in the
intestine was ranging from 7 up to 9 log CFU/g (Figure 8). Intestinal
bacterial populations increased with the encapsulated synbiotic
dietary treatments (30th day), but did not occur in control treat-
ments. The intestinal bacterial population also increased after
challenge test. However declined intestinal bacterial population
was noted at 35th day and 40th day in treatments A, B, and C, but not
in the PC. The lowering of the intestinal bacterial population was
most probably caused by the decreasing population of Bacillus NP5
RfR and V. harveyi RfR in the intestine (Figure 9). Bacillus NP5 RfR
populations in the intestine were relatively low on 35th and 40th
day, but the B and C treatments of Bacillus NP5 RfR populationwere
still higher than A treatment. On the other hand, the population of
V. harveyi RfR at all shrimps treated with encapsulated synbiotic
diet was not found in intestines (Figure 9).4. Discussion
SR of treatment A, B, and C was higher than PC which indicated
that encapsulated synbiotic dietary gave positive effect to increase
resistance against V. harveyi infection. The applications of synbiotic
with combination of 0.2% isomaltooligosaccharide prebiotic and
probiotic Bacillus OJ (PB) 8 log CFU/g of feed was significantly
higher (p < 0.05) and able to produce a positive synergistic effect on
the immune system of shrimp against white spot syndrome
virus infection (Li et al. 2009).
The results of this study also showed that the encapsulated
synbiotic dietary on feed provide a beneficial effect on growth
performance and FCR. Increasing growth rate was found along
increasing dosage. Latest research done by Widanarni et al. (2014)Figure 5. THC of L. vannamei. A: 0.5% encapsulated synbiotic dietary; B: 1% encapsu-
lated synbiotic dietary; and C: 2% encapsulated synbiotic dietary. ( ) Before V. harveyi
infection (the 30th day), ( ) 1 day after V. harveyi infection (the 32nd day); ( ) 9 days
after V. harveyi infection (the 40th day). NC ¼ negative control; PC ¼ positive control;
THC ¼ total hemocyte count.
Figure 6. PO of L. vannamei. A: 0.5% encapsulated synbiotic dietary; B: 1% encapsulated
synbiotic dietary; and C: 2% encapsulated synbiotic dietary. ( ) Before V. harveyi
infection (the 30th day), ( ) 1 day after V. harveyi infection (the 32nd day); ( ) 9 days
after V. harveyi infection (the 40th day). NC ¼ negative control; PC ¼ positive control;
PO ¼ phenoloxidase.
Figure 8. TVBC in the intestine of L. vannamei. A: 0.5% encapsulated synbiotic dietary;
B: 1% encapsulated synbiotic dietary; and C: 2% encapsulated synbiotic dietary. ( )
Before treatment of encapsulated synbiotic dietary (the 0 day); ( ) before V. harveyi
infection (the 30th day); ( ) 1 day after V. harveyi infection (the 32nd day); ( ) 4 days
after V. harveyi infection (the 35th day); ( ) 9 days after V. harveyi infection (the 40th
day). NC ¼ negative control; PC ¼ positive control; TVBC ¼ total viable bacterial count.
A. Zubaidah, et al166showed that growth rate increased with supplementation of pro-
biotic BacillusNP5 at a dose of 8 log CFU/mL. The increase of growth
ratewas assumed because of enzymatic activity in shrimp intestine.
Probiotic Bacillus NP5 that were used in this study were isolated
from tilapia intestinewhich is capable of secreting amylase enzyme
(Putra et al. 2015) and has been adapted to SWCmedium to survive
when exposed to sea water and in shrimp intestine. The amylase
enzyme acts as an exogenous enzyme (Taoka et al. 2007; Wang
2007). This enzyme was suggested to have capability to stimulate
endogenous enzyme that is produced by shrimps (Saeed et al.
2006), so feed that is absorbed in shrimp intestine can be
degraded effectively, then the optimum nutritional absorption can
be reached. Besides that, prebiotic also provided as the additional
nutrients for probiotic bacteria (Evivie 2013).
The lower FCR value in this study indicated that the shrimps fed
by encapsulated synbiotic dietary showed the effectivity in
nutrient digestibility. Similar result reported by Nurhayati et al.
(2015) that supplementation of synbiotic SKT-b gave a significant
effect on the growth and feed conversion of shrimp (L. vannamei).
In observation of immune responses, THC value in this study
showed an increase after infection of V. harveyi for all treatment and
then declined. This means a rapid reaction of shrimp immunity to
infection. The treatment C showed no significant different before
and after infection of V. harveyi. This suggested that supplementa-
tion of encapsulated synbiotic with optimum dosage have the
capability to stimulate the production of hemocyte cell, therefore,
the infection did not affected the THC value. A study presented byFigure 7. Differential hemocyte count: (A) hyaline count; and (B) granular count. A: 0.5% e
sulated synbiotic dietary. ( ) Before V. harveyi infection (the 30th day), ( ) 1 day after V.
NC ¼ negative control; PC ¼ positive control.Chiu et al. (2007) showed that the probiotics was capable of
increasing the THC value as well as enhancing the immune
response during the period of stress because of pathogen infection.
Hemocyte cell count decline is an effect of the body's defense
mechanisms such as the infiltration of the networks of infected
hemocytes, and hemocyte cell death due to apoptosis mechanism
(Costa et al. 2009). Pro-PO activity system and other humoral body
defense mechanisms also affect the number of hemocyte cells
(Huang et al. 2013; Tassanakajon et al. 2013).
The increase and decrease of THC were due to the increase and
decrease components of its hemocyte cells. Hemocyte consists of
three types of granules in the cytoplasm, i.e. the hyaline, granular
and semigranular hemocytes. The percentage of granular cells and
semigranular in this study was made into one group, namely the
percentage of granular cells. The hyaline and granular cells
contributed to destroy the antigen at shrimp body through
phagocytosis, encapsulation, nodule formation and produced hu-
moral components. Humoral components are stored in
granule hemocyte which include anticoagulant protein, aglutinin,
PO enzymes, antimicrobial peptides, and protease inhibitors
(Jiravanichpaisal et al. 2006).
PO is an enzyme responsible for melanization process in crus-
taceans as response to antigen and for pigmentation (Zufelato et al.
2004). PO system can be activated by several microbe poly-
saccharides and specific pattern recognition proteins, such as LPS
(lippo polysaccharides) and b-1, 3-glucan-binding protein and
peptidoglycan-binding proteins (Wang 2007). The treatment Cncapsulated synbiotic dietary; B: 1% encapsulated synbiotic dietary; and C: 2% encap-
harveyi infection (the 32nd day); ( ) 9 days after V. harveyi infection (the 40th day).
Figure 9. (A) Bacillus NP5 RfR count; and (B) V. harveyi RfR count in the intestine of L. vannamei. A: 0.5% encapsulated synbiotic dietary; B: 1% encapsulated synbiotic dietary; and C:
2% encapsulated synbiotic dietary (the 0 day); ( ) before V. harveyi infection (the 30th day), ( ) 1 day after V. harveyi infection (the 32nd day); ( ) 4 days after V. harveyi infection (the
35th day); ( ) 9 days after V. harveyi infection (the 40th day). NC ¼ negative control; PC ¼ positive control.
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declined after infection. Increasing of PO activity has caused the
shrimp's ability to recognize antigen that enters the body’s system
(Garcia-Carreno et al. 2008). The increase of PO value before
infection was the effect of dietary supplementation by encapsu-
lated synbiotic. Probably, the supplementation of probiotic Bacillus
NP5 has increased the b-1, 3-glucan-binding protein content in the
gut shrimp, as it has been reported by Hao et al. (2014) which
resulted in improvement of PO system. Other study reported that
the decline of PO is a sign of recovery period from V. harveyi
infection (Huang et al. 2013).
Encapsulated synbiotic dietary increased the population of
bacteria in shrimp intestine up to 9 log CFU/g. Similar result was
reported by Li et al. (2007) that the addition of short-chain fructo-
oligosaccharides was able to increase the growth of bacteria in the
shrimp digestive tract. The growth of bacteria in shrimp intestine
dominated by probiotic Bacillus NP5 RfR indicated by its population
which reached 5 log CFU/g. This suggested that Bacillus NP5 RfR,
supplied with prebiotics which has been encapsulated, was able to
stick well and utilizes prebiotics on shrimp intestine. The addition
of prebiotic oligosaccharides can improve the shrimp health
because the existence of beneficial intestinal bacteria suppresses
potentially pathogenic bacteria (Ringo et al. 2010). This statement
reinforces findings that encapsulated synbiotic dietary was also
able to suppress the growth of V. harveyi in shrimp intestine.
In summary, the encapsulated synbiotic dietary for 30 days with
different dosages gives significant effects on the growth perfor-
mance and FCR. The best dosage was shown by application of 2%
encapsulated synbiotic dietary (treatment C). The supplemented
diet by 2% encapsulated synbiotic showed significantly higher
growth performance (2.98 ± 0.42%), FCR (1.26 ± 0.19), and immune
responses to V. harveyi infection than control treatments.Conflict of interest
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